000 01694 a2200421 4500
005 20250516100803.0
264 0 _c20130628
008 201306s 0 0 eng d
022 _a1432-0932
024 7 _a10.1007/s00586-012-2404-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLippuner, Kurt
245 0 0 _aRecommendations for raloxifene use in daily clinical practice in the Swiss setting.
_h[electronic resource]
260 _bEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
_cDec 2012
300 _a2407-17 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAged
650 0 4 _aBreast Neoplasms
_xprevention & control
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aOsteoporosis, Postmenopausal
_xprevention & control
650 0 4 _aRaloxifene Hydrochloride
_xtherapeutic use
650 0 4 _aRisk Factors
650 0 4 _aSelective Estrogen Receptor Modulators
_xtherapeutic use
650 0 4 _aSwitzerland
700 1 _aBuchard, P A
700 1 _aDe Geyter, C
700 1 _aImthurn, B
700 1 _aLamy, O
700 1 _aLitschgi, M
700 1 _aLuzuy, F
700 1 _aSchiessl, K
700 1 _aStute, P
700 1 _aBirkhäuser, M
773 0 _tEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
_gvol. 21
_gno. 12
_gp. 2407-17
856 4 0 _uhttps://doi.org/10.1007/s00586-012-2404-y
_zAvailable from publisher's website
999 _c21900535
_d21900535